Volume Alert - GNW 9.39 Genworth Financial Inc $GNW Hit a

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GNW 9.39 Genworth Financial Inc $GNW Hit a high today of 9.42 Closing the day 10:30 at 9.39 -0.02 -0.21% With a day low of 9.25 and a total volume of 1,946,272.

GNW Recent Posts: http://investorshangout.com/Genworth-Financia...GNW-51181/

GNW Genworth Financial Inc Recent Headline News

Most active New York Stock Exchange-traded stocks
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
F: 15.35 (+0.21), HTZ: 21.92 (+0.23), P: 20.47 (-1.04), HAL: 49.94 (-5.14), BAC: 17.03 (-0.11), TWTR: 40.73 (-1.12), GNW: 9.33 (-0.08), BHI: 66.07 (+6.18)

NYSE stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
CJES: 18.51 (-1.44), AEO: 13.52 (+0.02), EVDY: 13.49 (-0.06), VSLR: 11.40 (-0.53), MTOR: 13.98 (-0.12), TWTR: 40.73 (-1.12), CRCM: 8.61 (-0.24), GNW: 9.33 (-0.08), MATX: 33.85 (-0.36), CSH: 24.00 (-0.53), BHI: 66.06 (+6.17)

Genworth Study Reveals Americans Would Rather Go to the Dentist Than Talk about Their Long Term Care Planning and Aging Needs
PR Newswire - Thu Nov 13, 1:00PM CST
One out of every four adults would rather go to the dentist than talk about their long term care or aging needs. "While the data stating people would rather sit in a dentist chair than talk about long term care might seem amusing, the severity of the issue is very real," said Tom McInerney, President and Chief Executive Officer at Genworth.
GNW: 9.33 (-0.08)

One Reason Genworth Financial (GNW) Stock is Rising Today
at The Street - Thu Nov 13, 10:50AM CST
Shares of Genworth Financial (GNW) were up in late morning trading Thursday after Raymond James upgraded the stock to 'outperform' from 'market perform.'
GNW: 9.33 (-0.08)

Small bounce for Genworth as it finds another sell-side fan
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 7:48AM CST

GNW: 9.33 (-0.08)

Upgrade Alert for Genworth Financial (GNW)
Comtex SmarTrend(R) - Thu Nov 13, 6:55AM CST
Genworth Financial (NYSE:GNW) was upgraded from Market Perform to Outperform at Raymond James today. The stock closed yesterday at $8.80 on volume of 28.4 million shares, above average daily volume of 10.1 million. Genworth Financial Inc. offers insurance, wealth management, investment and financial solutions The Company offers products that include life insurance products, long-term care insurance, and mortgage guarantee insurance coverage on residential mortgage loans. Genworth is active in the United States, Canada, Australia, New Zealand, Mexico and multiple European countries.
GNW: 9.33 (-0.08)

Watch for Genworth Financial to Potentially Pullback After Gaining 4.76% Yesterday
Comtex SmarTrend(R) - Wed Nov 12, 4:01PM CST
Genworth Financial (NYSE:GNW) traded in a range yesterday that spanned from a low of $8.33 to a high of $8.93. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $8.75 on volume of 27.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GNW: 9.33 (-0.08)

Genworth Financial Rises 4.76% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Nov 12, 4:00PM CST
Genworth Financial (NYSE:GNW) traded in a range yesterday that spanned from a low of $8.33 to a high of $8.93. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $8.75 on volume of 27.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GNW: 9.33 (-0.08)

Genworth Financial (GNW) Crosses Pivot Point Resistance at $8.54
Comtex SmarTrend(R) - Wed Nov 12, 9:33AM CST
Genworth Financial (NYSE:GNW) has opened bullishly above the pivot of $8.32 today and has reached the first level of resistance at $8.54. Investors may be interested in a cross of the next upside pivot targets of $8.68 and $9.04.
GNW: 9.33 (-0.08)

3 Financial Stocks Driving The Sector Higher
at The Street - Tue Nov 11, 11:05AM CST
TheStreet highlights 3 stocks pushing the financial sector higher today.
UBS: 17.41 (-0.13), GNW: 9.33 (-0.08), BAP: 160.22 (+0.85)

Genworth: Opportunity Knocks
Hawkinvest - at Seeking Alpha - Mon Nov 10, 3:31PM CST

GNW: 9.33 (-0.08)

Genworth downgraded at KBW, defended at Macquarie
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:35AM CST

GNW: 9.33 (-0.08)

Downgrade Alert for Genworth Financial (GNW)
Comtex SmarTrend(R) - Mon Nov 10, 7:57AM CST
Genworth Financial (NYSE:GNW) was downgraded from Outperform to Market Perform at Keefe Bruyette today. The stock closed yesterday at $8.41 on volume of 77.0 million shares, above average daily volume of 7.1 million. In the past 52 weeks, shares of Genworth Financial have traded between a low of $7.17 and a high of $18.74 and closed yesterday at $8.40, which is 17% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has declined 1.7%.
GNW: 9.33 (-0.08)

Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
PR Newswire - Mon Nov 10, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Alibaba (NYSE:BABA), Genworth Financial (NYSE:GNW), Gilead Sciences (NASDAQ:GILD), Zynga (NASDAQ:ZNGA), Abercrombie & Fitch (NYSE:ANF), and Plug Power (NASDAQ LUG).
GILD: 100.63 (-1.43), PLUG: 3.75 (+0.03), ANF: 29.17 (+0.27), ZNGA: 2.67 (-0.10), GNW: 9.33 (-0.08), BABA: 114.03 (-1.07)

Genworth Financial Inc. (GNW) Stock Research Links

GNW Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 184

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 341

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 174

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 136

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 300

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading

Top 5 Most Recently Viewed Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 558

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
ParaZero Technologies Achieves Nasdaq Compliance Milestone

Updated Category News Views 130

ParaZero Technologies Regains Compliance with Nasdaq Standards Recent developments in the aerospace sector have highlighted the impressive strides made by ParaZero Technologies Ltd. (Nasdaq: PRZO), an innovator in safety systems for drones and urban air mobility vehicles. The company has reached a significant milestone, regaining compliance with Nasdaq’s minimum bid...

Continue Reading
Revolutionizing Semiconductor Design with AI Integration

Updated Category News Views 389

Ricursive Intelligence Launches Groundbreaking AI Lab Ricursive Intelligence is setting a new standard in semiconductor design with the introduction of its innovative AI lab. This initiative aims to seamlessly blend artificial intelligence with chip creation to expedite progress within the tech landscape. Major Funding and Valuation Boost The company recently raised an...

Continue Reading
Craneware plc Publishes a Key Trading Disclosure Notice

Updated Category News Views 219

Introduction to Craneware plc's Trading Disclosure Craneware plc, a prominent player in the healthcare technology space, has officially announced a significant trading disclosure following the rules established in the Takeover Code. This notification serves as an important communication to stakeholders about recent trading activities that involve exempt principal traders...

Continue Reading
Stocks to Consider Amidst Global Market Uncertainty

Updated Category News Views 150

The Current Market Landscape As geopolitical tensions rise, markets are experiencing undercurrents of uncertainty. Recent tariff threats have sent ripples through global financial markets, particularly affecting investor confidence in stocks. The atmosphere is becoming increasingly cautious, with many investors wondering which stocks might shield their portfolios during...

Continue Reading